Business
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer of critical reagents for the discovery, development, and commercialization
About this update from Alpha Teknova, Inc.
[{"type":"image","alt":"Alpha Teknova, Inc.","displaySize":"","headline":null,"caption":"Alpha Teknova, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":58,"url":"https://media.zenfs.com/en/globenewswire.com/df2ff657ca48a3da043108ece262fc87"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HeH6DhTJ3_7i2OIdUQNQNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/df2ff657ca48a3da043108ece262fc87","width":300,"height":58}},"lazy":false},{"type":"text","content":"Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.","length":151,"tagName":"p"},{"type":"text","content":"HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, while Pluristyx is a leading provider of induced Pluripotent Stem Cells (iPSCs), including immune evading and safety-switch enabled iPSCs, and other innovative technologies designed to shorten the development lifecycle of tomorrow’s cell therapies.","length":660,"tagName":"p"},{"type":"text","content":"As previously announced, Teknova and Pluristyx are collaborating to produce and commercialize the PluriFreeze product line, with Teknova becoming the exclusive manufacturer and distributor in the United States and Canada. The PluriFreeze cryopreservation system is entirely synthetic and animal-origin-free, and includes a unique protective wash paired with a proven freezing medium to streamline development and commercialization of next generation allogeneic cell therapies. PluriFreeze Base is a cellular wash that mimics intracellular space and provides end-to-end metabolic support. PluriFreeze PF10 is a low viscosity freezing medium with 10% dimethyl sulfoxide (DMSO) that simplifies scale-up and process automation.","length":723,"tagName":"p"},{"type":"text","content":"“Making solutions possible for our customers is our focus at Teknova,” said Jennifer Henry, Teknova’s Senior Vice President of Marketing, “a...